Relative Strength Chart Quoin Pharmaceuticals, Ltd.
Equities
QNRX
US74907L4095
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.480 USD | -2.97% |
|
-4.61% | -62.77% |
| 07-08 | Quoin Pharmaceuticals & CFO Gordon Dunn agree to a mutual separation | RE |
| 07-08 | Quoin Pharmaceuticals Ltd. Announces Mutual Separation with CFO Gordon Dunn | CI |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| QUOIN PHARMACEUTICALS, LTD. | Other Biotechnology & Medical Research | -2.97% | -4.61% | -62.77% | -63.29% | - | 4.99M |  |  | |
- Stock Market
- Equities
- QNRX Stock
- Charts Quoin Pharmaceuticals, Ltd.
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition